Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Contributing EditorIndividualAuthor
In Reply: We acknowledge that the average LOS
is shorter in the United States than in Canada. Differences also may exist
in quality of care, patient satisfaction, and outcomes. However, the optimum
LOS for community-acquired pneumonia has not been established. The statement
of Drs Burgess and Lewis that "patients are discharged approximately 1 day
after conversion to oral therapy" in the United States is based on a single-center,
uncontrolled, descriptive study.1 Importantly,
quality of life was not evaluated. Therefore, whether this policy is consistent
with good patient care or is common throughout the United States is unknown.
Feagan BG, Marrie TJ, Lau CY, et al. A Critical Pathway for Treatment of Community-Acquired Pneumonia—Reply. JAMA. 2000;283(20):2654–2655. doi:10.1001/jama.283.20.2653
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: